Generative AI’s Technology Is Not Yet Fully Optimized for Healthcare
Summary
Generative artificial intelligence (AI) faces many growing pains as it seeks its footing. In a recent survey, management consulting firm Bain & Company reveals that the main barriers to generative AI in healthcare are a lack of resources, expertise and regulation, with data access and quality and organizational resistance close behind. The recurring theme across industry studies is that generative AI in healthcare is nascent and needs time to prove its efficacy and to earn public trust. Robust benchmarks will increase confidence. The lesson for technology companies, pharmaceutical firms and healthcare providers considering generative AI in their strategies is that the technology is not yet fully optimized for healthcare. For generative AI to bear fruit, it needs investors, technology, resources, expertise, LLMs trained with healthcare-specific data, and robust guidelines. Ultimately, society needs to be ready for and comfortable with the involvement of generative AI in managing patient health and treatment. The task ahead entails expanding resources and expertise, training models on healthcare-specific data and establishing robust benchmarks. In time, through multiple iterations, generative AI will sharpen its analysis. Developers will fine-tune the benchmarks and criteria used in their models, aligning them with emerging regulatory guidelines. The result will be improved accuracy in diagnoses and recommended treatments. Ethical guidelines and human readiness will shape generative AI use and governance. Regulators are urged to move fast, but doing so too quickly could bring unintended consequences. The same caution applies to technology companies that are eager to earn a profit from their innovations. AI tools that gain FDA approval are setting a precedent for what will become commonplace in the future. The potential downside may be that ethical dilemmas will prompt companies and regulators to reconsider their positions. According to a recent study, Americans have mixed feelings about the use of generative AI in their healthcare. While they are enthusiastic about the potential benefits, most Americans are hesitant to replace their medical professionals with this technology. These sentiments may shift over time as technology matures and regulatory guidelines become more robust.The post Generative AI’s Technology Is Not Yet Fully Optimized for Healthcare first appeared on PYMNTS.com.
Bursting on stage to lead the final panel session of the day, Anna-Marie Slot, global sustainability partner, Ashurst, outlined her hopes for a “rubber hi…
Sustainable Finance Live 2023: Connecting capital with the right sustainability solutions
Blockchain
Summary
Bursting on stage to lead the final panel session of the day, Anna-Marie Slot, global sustainability partner, Ashurst, outlined her hopes for a “rubber hits the road” panel. Getting straight to the crux of the matter, Slot asked the panel, how much money actually has to move to ensure impact?
The post Kava ($KAVA) and InQubeta ($QUBE) Surge with the Launch of Ethereum ETFs appeared first on Coinpedia Fintech News The launch of Ethereum ($ETH) E…
Kava ($KAVA) and InQubeta ($QUBE) Surge with the Launch of Ethereum ETFs
Digital Currencies · Blockchain
Summary
The post Kava ($KAVA) and InQubeta ($QUBE) Surge with the Launch of Ethereum ETFs appeared first on Coinpedia Fintech News The launch of Ethereum ($ETH) ETFs this week didn’t bring the expected trading volume, with only $2 million in trades during its first day – but some of the projects built on its network, like InQubeta ($QUBE) and Kava ($KAVA), have enjoyed a price surge since then. Ethereum prices have dropped over 2% since the launch of six ETFs. Some analysts are already declaring $QUBE is one of the best altcoins to invest in this year thanks to factors like the creative way it makes it easier to invest in artificial intelligence (AI). The top DeFi project uses fractionalization, non-fungible tokens (NFTs), and smart contracts to create a secure, transparent, and accessible way for anyone to be part of the artificial intelligence revolution. Best altcoins to invest in: InQubeta ($QUBE) set to surge 21% when presale enters fifth stage The artificial intelligence revolution is set to shake up industries worldwide and InQubeta’s decentralized investment protocol positions it to be one of the top crypto coins that focus on advancing the technology. Investors have been extremely bullish on AI-focused companies for quite some time, with investments rising from $12 billion to $120 billion from 2015 to 2022. The AI party is just getting started with investments in the industry anticipated to exceed $1.5 trillion in the next several years. InQubeta helps those who don’t have access to traditional investment mediums by providing a hassle-free alternative that doesn’t come with the stringent requirements that some mainstream firms have, like minimum deposits of over $25,000. Technological breakthroughs always create new investment opportunities and those who invest in AI position themselves to earn massive profits as the technological revolution unfolds. Here’s how InQubeta’s investment protocol works: AI startups are assessed by InQubeta’s operations team before getting access to its NFT marketplace These firms mint investment opportunities into NFTs. Think of these tokens as InQubeta’s version of stocks. Unlike many of the most popular NFTs around that are valued on only speculation, the values of the tokens sold on InQubeta’s marketplace are based on the value of the tangible and intangible assets of the companies that made them NFTs are fractionalized so investors can invest as much or as little as they choose to NFTs are transferred to investor wallets and their value can be checked in each user’s InQubeta account. These tokens can be resold on the marketplace at any time Investing in the InQubeta protocol $QUBE being capped at 1.5 billion and the burn taxes on the marketplace virtually guarantee long-term price growth. $QUBE only needs to reach a $1.5 billion market cap for tokens to be priced around a dollar which would bring investors 100x returns on their capital. It should only be a matter of time before $QUBE’s market cap gets that high, given the solutions the project provides, the $1.5 trillion expected to pour into AI, and the fact that low-utility meme coins like Dogecoin ($DOGE) and Shiba Inu ($SHIB) have generated $9 billion and $4 billion market caps respectively. Kava ($KAVA) enjoys a small surge after $ETH ETFs launch, what’s next? $KAVA prices enjoyed price growth earlier in the week, but resistance was found at $0.66 and prices are once again trending downward. The Kava project connects the Cosmos ($ATOM) and Ethereum blockchains, allowing for the transfer of assets and data. Its protocol also rewards the best developers on both blockchains. Market metrics like $KAVA’s relative strength index at 46 and its ten-day simple moving average at 0.62 indicate now might be the time to trade for more profitable crypto projects like InQubeta. Summary $QUBE is poised for substantial growth as the InQubeta project becomes one of the hottest topics in the crypto space. Its presale offering 3x returns during its remaining stages makes it one of the best altcoins to invest in right now. Visit InQubeta Presale Join The InQubeta Communities
The Securities and Exchange Commission has been ordered by a court to explain its reasons for rejecting an application for a crypto-based exchange-traded …
The SEC needs to provide more clarity around crypto ETFs
Digital Currencies
Summary
The Securities and Exchange Commission has been ordered by a court to explain its reasons for rejecting an application for a crypto-based exchange-traded fund. It's about time.
The Markets in Financial Instruments Directive (MiFID) license will soon allow the firm to offer S&P 500 stocks. In addition, Xapo, which has always been …
Crypto Bank Xapo Snags European Broker License, Will Offer Stocks Like Apple
Digital Currencies · Blockchain
Summary
The Markets in Financial Instruments Directive (MiFID) license will soon allow the firm to offer S&P 500 stocks. In addition, Xapo, which has always been bitcoin-only, plans to add Ethereum’s ETH.